Oxazepam
Back to searchMolecule Structure
Scientific Name
Oxazepam
Description of the Drug
Oxazepam is an intermediate-acting benzodiazepine with slow onset commonly used to treat panic disorders, severe anxiety, alcohol withdrawals, and insomnia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00842
http://www.drugbank.ca/drugs/DB00842
Brand Name(s)
Lederpam, Oxazepam, Serax, Serenid fte, Zaxopam
Company Owner(s)
Parke Davis Div Warner Lambert Co, United Research Laboratories Llc, Sun Pharmaceutical Industries Inc, Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Alpharma Us Pharmaceuticals Division, American Therapeutics Inc, Watson Laboratories Inc, Epic Pharma Inc, Actavis Elizabeth Llc, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL27435 |
| PharmGKB | PA450731 |
| Human Metabolome Database | HMDB0014980 |
| DrugBank | DB00842 |
| PubChem: Thomson Pharma | 14848993 |
| PubChem | 4616 |
| NMRShiftDB | 20182033 |
| Nikkaji | J3.308A |
| BindingDB | 85031 |
| EPA CompTox Dashboard | DTXSID1021087 |
| DrugCentral | 2015 |
| Brenda | 11744 |
| Guide to Pharmacology | 7253 |
| rxnorm | OXAZEPAM |
| KEGG Ligand | C07359 |
| ChEBI | 7823 |
